Ibd clinical trials

Explore recruiting ibd clinical trials.

Recruiting ibd studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ibd trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Modafinil for debilitating fatigue in quiescent inflammatory bowel disease: a multicentre, randomised, double-blind, placebo-controlled, clinical trial (MODIFI-IBD trial)

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 3b Extension Study to Evaluate the Long-term Safety of Vedolizumab Intravenous in Pediatric Patients With Ulcerative Colitis or Crohn's Disease

Greece, Poland, Belgium, Croatia, Italy, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind Long-Term Extension Study to Evaluate Pharmacokinetics, Efficacy, Safety, and Tolerability of TEV-48574 in Adult Patients with Moderate to Severe Ulcerative Colitis or Crohn’s Disease who completed the treatment phase of the Dose-Ranging Study (RELIEVE UCCD LTE)

Austria, Slovakia, Hungary, Germany, Spain, Czechia +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics with Multiple Therapies in Participants with Active Crohn’s Disease or Active Ulcerative Colitis (ASCEND-IBD)

Poland, Bulgaria, Croatia, Germany, Belgium, Slovakia +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease Long-term Safety With Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease.

Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Subcutaneous vedolizumab drug de-escalation in inflammatory bowel disease: a multicentre randomised controlled study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Ibd trials by city

Ibd in Toronto Ibd in Vancouver Ibd in Montreal Ibd in Calgary Ibd in Edmonton Ibd in Ottawa Ibd in Winnipeg Ibd in Quebec City Ibd in Hamilton Ibd in Kitchener Ibd in London Ibd in Halifax Ibd in New York Ibd in Los Angeles Ibd in Chicago Ibd in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease